Trial intelligence / Profile preview

Different-dose intravenous methylprednisolone for prevention of maternal fever during labor analgesia

ChiCTR1900024125Phase 4Recruiting

Sponsor
Southern Medical University Zhujiang Hospital
Start
Jul 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of methylprednisolone in Intrapartum fever (IPF) (3 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Body temperature. Started Jul 2019; status: recruiting.

02

Drugs

methylprednisolone
03

Conditions

Intrapartum fever (IPF)

Beyond the preview

Go deeper on ChiCTR1900024125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900024125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call